University of Louisville

ThinkIR: The University of Louisville's Institutional Repository
Faculty Scholarship
5-2013

A home-based exercise intervention to increase physical activity
among people living with HIV: study design of a randomized
clinical trial
Jason R. Jaggers
University of Louisville, jason.jaggers@louisville.edu

Wesley Dudgeon
The Citadel

Steven N. Blair
University of South Carolina

Xuemei Sui
University of South Carolina

Stephanie
Burgess
Follow this and
additional works at: https://ir.library.louisville.edu/faculty
University of South Carolina
Part of the Exercise Science Commons, Immune System Diseases Commons, and the Sports
Sciences
Commons
See next page
for additional authors

Original Publication Information
Jaggers, J.R., Dudgeon, W., Blair, S.N. et al. "A home-based exercise intervention to increase physical
activity among people living with HIV: study design of a randomized clinical trial." 2013 BMC Public Health
13:502.

ThinkIR Citation
Jaggers, Jason R.; Dudgeon, Wesley; Blair, Steven N.; Sui, Xuemei; Burgess, Stephanie; Wilcox, Sara; and
Hand, Gregory A., "A home-based exercise intervention to increase physical activity among people living
with HIV: study design of a randomized clinical trial" (2013). Faculty Scholarship. 417.
https://ir.library.louisville.edu/faculty/417

This Article is brought to you for free and open access by ThinkIR: The University of Louisville's Institutional
Repository. It has been accepted for inclusion in Faculty Scholarship by an authorized administrator of ThinkIR: The
University of Louisville's Institutional Repository. For more information, please contact thinkir@louisville.edu.

Authors
Jason R. Jaggers, Wesley Dudgeon, Steven N. Blair, Xuemei Sui, Stephanie Burgess, Sara Wilcox, and
Gregory A. Hand

This article is available at ThinkIR: The University of Louisville's Institutional Repository: https://ir.library.louisville.edu/
faculty/417

Jaggers et al. BMC Public Health 2013, 13:502
http://www.biomedcentral.com/1471-2458/13/502

STUDY PROTOCOL

Open Access

A home-based exercise intervention to increase
physical activity among people living with HIV:
study design of a randomized clinical trial
Jason R Jaggers1,5*, Wesley Dudgeon2, Steven N Blair1,4, Xuemei Sui1, Stephanie Burgess3, Sara Wilcox1
and Gregory A Hand1

Abstract
Background: While combination antiretroviral therapy has extended the life expectancy of those infected with
human immunodeficiency virus (HIV), there is a high prevalence of comorbidities that increase the risk of
cardiovascular morbidity and mortality among people living with HIV/AIDS (PLWHA). The side effects associated
with antiretroviral therapy (ART) lead to multiple metabolic disorders, making the management of these metabolic
issues and risk of cardiovascular disease (CVD) in those treated with ART a critical issue. Clinical research trials,
primarily clinical exercise, rarely include this population due to unique challenges in research methods with
underserved minority populations living with a life threatening illness like HIV/AIDS. This paper describes the
rationale and design of a randomized clinical trial evaluating the feasibility of a home-based exercise program
designed to increase physical activity (PA) and reduce the risk of CVD in PLWHA.
Methods/design: PLWHA being treated with ART will be randomly assigned to one of two groups: a home-based
PA intervention or standard care. All participants will receive an educational weight loss workbook and pedometer
for self-monitoring of PA. Only those in the intervention group will receive additional elastic Thera-bands® for
strength training and behavioral telephone based coaching.
Discussion: This study will evaluate the feasibility of a home-based program designed to increase PA among
PLWHA. Further, it will evaluate the effectiveness of such a program to decrease modifiable risk factors for CVD as a
secondary outcome. This study was funded by the NIH/NINR R21 Grant 1R21NRO11281.
Trial registration: Clinical Trial Identifier NCT01377064
Keywords: Randomized trial, Cardiovascular disease, HIV, Physical activity, Self care, Study design

Background
People living with HIV/AIDS (PLWHA) are at an increased risk for cardiovascular disease (CVD) once they
begin taking antiretroviral therapy (ART). Studies that
control for traditional CVD risk factors show a detrimental effect of ART on CVD risk in PLWHA. For example, the incidence of myocardial infarction (MI)
increases directly with increased exposure to specific
ART regimens [1,2]. The majority of known side effects
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associated with ART directly alter metabolic processes,
thus increasing the risk of metabolic syndrome. Symptoms of these side effects include lipodystrophy (abnormal fat displacement), hyperlipidemia (i.e. triglycerides,
cholesterol), decreased HDL-C, and impaired fasting glucose among others [3,4]. Similar symptoms are commonly
observed among people known to be at an increased risk
for CVD, diabetes, and other chronic diseases.
Extensive research has established the benefits of routine PA in the general population, including decreased
risk of CVD [5]. PA is an appropriate intervention for
reducing many modifiable risk factors of CVD, including
a number of those that are elevated with HIV infection
and/or treatment. Studies have shown that people of all
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ages infected with HIV have abnormally low levels of cardiorespiratory fitness (CRF) [6]. These reductions have
been attributed to sedentary behavior and lifestyle habits.
Further, PLWHA often exhibit a maximal VO2 of 24% 44% below their age-predicted normal values [6]. CRF, as
determined by a maximal VO2 test, is a powerful predictor of all-cause and CVD mortality[7,8] and of type 2
diabetes mellitus [9]. Short duration studies have shown
significant increases in CRF with moderate or high intensity PA training in as little as 6 to 12 weeks as well as a
dose response to aerobic activity [6,10]. Other beneficial
physiological and anthropomorphic adaptations include
increased serum HDL-C, decreased triglycerides and total
cholesterol [11,12], and reduced BMI, waist-to-hip ratio,
and overall body fat [13]. Recent studies show that muscular strength is inversely associated with risk for metabolic
syndrome and all-cause mortality [14,15].
PA interventions that require regular attendance at a
facility are not ideal for populations that are more likely
to be financially disadvantaged, such as PLWHA, due to
barriers related to transportation, access, and cost. We
have used home-based PA programs successfully with
various populations [16-18]. These programs have targeted healthy populations and those with heart failure,
cancer, sporadic inclusion body myositis (IBM), chronic
obstructive pulmonary disorder (COPD), and outcomes
associated with various inflammatory responses [19-22].
Other trials have focused on functional outcomes such
as the ability to complete tasks of daily living, or overall
cardiorespiratory fitness [23,24]. These programs incorporated moderate intensity PA, which has been proven
to be safe for clinical populations with functional limitations [23,24]. Telephone delivered home-based interventions have been found to be effective in promoting PA in
general populations of adults, and this intervention approach has been recommended for wider dissemination
[25]. The purpose of this paper is to describe the detailed methods for a randomized clinical trial of a telephone delivered home-based PA program designed to
increase physical activity and reduce the risk of CVD
in PLWHA.

Methods
This randomized clinical trial is being conducted to test
the effectiveness a 9-month home based PA intervention. Further, we will examine the effects of routine PA
relative to a standard of care group. Physical and psychological testing, as well as blood sampling, is being
performed on each participant at baseline, 18 weeks, and
36 weeks. Measurements will include either direct measurement or measurement of surrogate markers/indices
for body composition, stress and health-related quality
of life, blood lipids and inflammatory markers, and glucose metabolism.
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Description and selection criteria for participants

All participants were recruited between 2010–2012 from
one of two sites via physician reference or word of mouth;
the greater Columbia, South Carolina area or the Charleston, South Carolina area. Study staff recruited underactive
men and women 18 years of age or older with a positive
HIV serostatus and on ART. Inclusion and exclusion criteria for this study are shown in Table 1.
Participant screening

Figure 1 shows a flow chart of the study as participant’s
progress through, beginning with an initial telephone prescreening interview. Potential participants were asked general eligibility questions regarding their age, HIV status,
current ART prescription, and telephone access over the
next 10 months. All eligible participants who wished to
learn more about the study were invited to a study orientation session.
At the study orientation, a staff member gave a slide
presentation explaining the purpose of the study and study
expectations of participants. This presentation included
the participant responsibilities and potential health benefits and risks related to study participation. Participants
were given an opportunity to ask questions about the
study and those who wished to participate signed an
informed consent approved by the University of South
Carolina’s Internal Review Board and completed further
questionnaires requesting contact and demographic information. All eligible participants who signed the informed
consent were scheduled to take part in a run-in period.
During the run-in period participants were asked to
complete additional self-report questionnaires as described below. Trained staff also obtained the following
standardized measurements: resting blood pressure,
height, weight, waist and hip circumference, and a fasted
blood draw. To avoid measurement error, each measurement is obtained in triplicates with the average of the
two closest as the primary value used for data collection.
All participants are instructed not to eat or drink anything except water at least 8 hours prior to their scheduled run-in visit. At the end of the session participants
were given a SenseWear® armband designed to measure
daily PA with oral and written instructions for proper
wear. Participants were instructed to wear the armband
at all times except while bathing or swimming until they
returned for baseline testing. The run-in activities serve
several purposes. First, wearing an armband allows participants to better understand what type of activities
would be required in the study and to see if the participant would be compliant with attending multiple study
visits, as required by the trial. The goal is to screen out
participants unlikely to adhere to study requirements.
The second reason for including the run-in period and
session is to reduce participant burden at the orientation
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Table 1 Inclusion/exclusion criteria
Inclusion criteria
• Age 18 years and older
• Medical diagnosis of HIV-1 positive serostatus
• Sedentary lifestyle: not actively exercising ≥ 3 d · wk-1 for 20 min per session
• Stable, DHHS-approved ART regimen for previous 3 months, with HIV viral load below 75 copies/mL
• Capable of performing the required exercise regimen
• Have daily access to a telephone for approximately 10 months
• Capacity and willingness to provide informed consent and accept randomized group assignment
Exclusion criteria

Temporary exclusion criteria

• Individuals who have a clinical history strongly suggestive of
Type 1 diabetes.

• Total cholesterol ≥240 mg/dl with LDL-C ≥160 mg/dl or TG levels
≥300 mg/dl. Note: Individuals on cholesterol lowering medications
but meeting blood lipid requirements are eligible.

• History of serious arrythmias, cardiomyopathy, congestive heart failure,
stroke or transient ischemic cerebral attacks, peripheral vascular disease
with intermittent claudication, myocardial infarction, or CABG.

• Resting blood pressure >160 systolic and/or 90 diastolic.
Note: Individuals on blood pressure medications but meeting blood
pressure criteria are eligible.

• Malignancies in the past 5 years, except therapeutically controlled
skin cancer.

• HbA1c ≥11%. Individuals whose HbA1c exceeds this level will be
recommended to seek treatment immediately. Such individuals may
be re-screened after three months to re-assess HbA1c eligibility.

• Plans to be away > 4 weeks in the next 9 months.

• Current opportunistic infection at the time of screening.

• Score of 5 or greater on the DAST or MAST
(signifying excessive use of drugs or alcohol).

• Participation in another intervention trial.

• Weight loss in excess of 10% body weight in previous 12 weeks.

• Other temporary intervening event, such as sick spouse, bereavement,
or recent move.

• Chronic or recurrent respiratory, gastrointestinal, neuromuscular,
neurological, or psychiatric conditions.
• Inflammatory-related conditions such as collagen disorders.
• Any other medical condition or disease that is life-threatening
or that can interfere with or be aggravated by exercise.

and baseline assessments by spreading the questionnaires across multiple visits.
Participants returned for their baseline session 7–10
days after the run-in. At this time the armband was collected and PA data was immediately uploaded into the
dataset. Participants are not provided with any data retrieved from the armband at this time. During this session all participants completed a maximal exercise stress
test with a 12-lead ECG and breath by breath oxygen
analyzer. All tests were completed on a treadmill and supervised by the study medical director. Following successful completion of the exercise test and clearance for
participation by the medical director, study participants
were randomized.
Randomization

After successfully completing all screening visits (orientation, run-in, and baseline assessment), eligible participants were randomized into 1 of 2 groups: standard care
or intervention. Both groups received an evidence-based
book on healthful eating and regular physical activity
[26] and a pedometer. Those randomized into the intervention group received a one-on-one PA training session
to explain in further detail participant expectations and

demonstrate proper use of the elastic Thera-Bands® for
strength training. The physical activity education session
provides an overview of what constitutes physical activity, benefits of physical activity, different types of physical activity, current physical activity recommendations,
tips for starting a physical activity program and proper
use of the physical activity log. In addition to the education session the health educator worked with each participant to help them establish reasonable short term goals
that would eventually lead up to a common long term goal
among the participants (≥ 150 minutes of routine PA per
week and 2–3 resistance training sessions per week).
Follow-up examinations

Participants are scheduled to return for a follow-up data
collection visit that occurs at 18- and 36- weeks after
randomization. The same measurements and questionnaires completed during the run-in session are assessed
during each follow-up visit. All sessions are completed
in the morning following an 8 hour fast. Participants are
also given the armband to wear for 7–10 days, with detailed oral and written instructions for proper use. Participants are scheduled to return 7–10 days later to return
the armband.
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Telephone screens

n=95

Orientation
1 hour visit
N=84
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well as a measure of total physical activity. Secondary
outcomes include physiological and psychological variables, such as cardiorespiratory fitness, adiposity and fat
distribution, full blood lipid panel, depression, anxiety,
stress, and health-related quality of life. Tertiary exploratory outcomes include assessment of serum CRP and IL-6.
Physical activity assessment

Run-in assessment
1 hour visit
n=74

Baseline assessment
1 hour visit
n=72

Physical activity will be assessed with the SenseWear®
armband, a commercially available (www.bodymedia.com)
lightweight physical activity monitor that is worn on the
upper left arm halfway between the acromion and olecranon processes. Using tri-accelerometry technology augmented by 2 heat sensors (a thermistor-based skin surface
sensor and a proprietary heat flux sensor), and a galvanic
skin response sensor, the device is able to accurately measure and record total energy expenditure, and also measures activity intensity. These 4 internal sensors turn on
the monitor when detecting skin contact and measures
total time the armband was worn, daily energy expenditure, step count, sleep efficiency, and the intensity, duration, and frequency of physical activity bouts. All armband
data will be analyzed by computer-based software using
demographic information (gender, age, height, and weight
at prior assessment) and proprietary algorithms.
Validity of SenseWear armband

Randomization
n=68

Standard Care
n=34

Intervention
n=34

18-week assessments

36-week assessments
Figure 1 Study flow chart.

Outcome measures and methods

The primary outcome of interest is physical activity, as
measured by the SenseWear® armband. These measurements will be used as an index of program adherence as

Validity of armband energy expenditure estimates has
been reported in several conditions including resting,
exercise (ie treadmill and cycle ergometry), and freeliving conditions (ie physical activity and exercise) [27-29].
St-Onge et al. found that when comparing the armband to
doubly labeled water daily energy expenditure had an
interclass correlation of 0.81 (P < 0.01) between the two
methods [30]. When comparing the armband to the Intelligent Device for Estimating Energy Expenditure and Activity (IDEEA) Welk et al. showed comparable results
between the armband and IDEEA when estimating energy
expenditure and PA [29].
Intervention
Components and approach

Two interventionists were trained by a clinical psychologist with expertise in behavioral interventions to implement the Active Choices program (developed at Stanford
University). Active Choices is a home-based physical activity program that uses theoretically-based strategies to
help participants make lifestyle changes. Active Choices is
based on both social cognitive theory [31] and the
transtheoretical model [32]. The intervention begins with
a 60-minute individual face-to-face session in which rapport was established; the program and expectations are
described; a PA and diet history is taken; realistic, specific,
and measurable short-term and long-term goals are set;
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safety information is provided; instructions for wearing a
pedometer is given; self-monitoring tools (pedometer and
log) are distributed; and a schedule for follow-up telephone calls is set.
The face-to-face session will be followed by regular
telephone counseling calls (15–20 minutes each). During
the initial adoption phase (weeks 1–8) participants will
receive telephone calls once a week. After the adoption
phase, participants will enter a transition phase (weeks
9–26) during which participants received a telephone
call every other week. The goal for the transition phase
is for the participants to work up to 150 minutes of
moderate- intensity physical activity and complete two
resistance training sessions. Following the transition
phase, participants begin a maintenance phase (weeks 27
to the end of the trial) where they will continue to receive a telephone call every other week. The exercise
regimens of weekly 150 minutes of moderate-intensity
PA and 2 resistance training sessions will also continue.
Although the Active Choices program recommends two
calls per month during the first two months and one call
per month thereafter, we believe that more regular contact is important with PLWHA. We anticipate that participants in our trial will be predominantly financially
disadvantaged, have many challenges to changing behavior, and would benefit from additional support. More
frequent contact also allows us to monitor participant
health and safety.
Each call will begin with a review of goals (cognitive or
behavioral) set on the last call, assessment of current
health and medical status and changes in status, and actual physical activity participation since the last call (type
of activities and total time spent doing each activity).
Participants will be encouraged to discuss barriers to
change (and the interventionist helped to engage the
participant in problem solving skills) as well as successes. The participant’s stage of readiness for change
will be assessed and this information, along with information learned about barriers and successes on previous
calls help to guide the selection of counseling topics/strategies for the call. For example, discussion of a cognitive
strategy such as becoming more aware of the benefits of
PA could be used for participants in precontemplation or
contemplation, whereas a behavioral strategy such as
enlisting social support could be discussed for participants
in later stages of change (preparation, action, maintenance). The interventionist will be provided a list of call
topics (i.e., cognitive or behavioral strategies and approaches that map onto the two theories) most appropriate for each stage of change. Over the course of the
intervention, the interventionist will be encouraged to
choose and discuss multiple call strategies that are most
relevant for the participant. Calls typically end with the
interventionist helping the participant select cognitive or
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behavioral goals for the next one to two weeks and
discussing ways to overcome barriers that may get in the
way of these goals. The interventionist may send a “tip
sheet” if they feel that participant needs additional information (e.g., exercising during the heat).
Frequent self-monitoring of physical activity, diet, and
weight will be strongly encouraged, as self-monitoring is
positively associated with behavioral adherence (32). A
pedometer will be used as a motivation and selfmonitoring tool. The health counselor will use minutes
per day of physical activity as part of goal setting activities (e.g., focusing on increasing weekly physical activity
time through 10-minute or more bouts of walking).
Non-exercise standard care group Since randomization occurred after the run-in period, the participants in
the standard care group received the same educational
material and weight loss manual just as those randomized to the PA group. Physical activity habits will be
monitored throughout the study for participants randomized to the standard care group in the same manner
as for the intervention group using the SenseWear® armband. One potential problem in this group is the possibility of participants losing interest in the study because
they are assigned to a “control” group. We have been
successful in reducing standard care group dropout in
previous studies by maintaining telephone contact with
standard care group participants. In this study, we will
contact the standard care group participants by telephone every two weeks to update health status, maintain
current contact information, and emphasize the importance of their participation for a successful study.
Testing procedures
Graded exercise stress test

Following a medical examination including evaluation of
family and personal medical history, resting blood pressure, and resting ECG evaluation, each participant completed a graded exercise stress treadmill test (GXT). The
GXT is used to screen for abnormal physiological responses to exercise, including blood pressure and ECG
responses, and for determining the participant’s current
level of cardiorespiratory fitness. The test is terminated
either at volitional exhaustion or at observation of abnormal responses that are contraindications for exercise.
This test has been found to be highly reproducible with
a high sensitivity to changes in VO2 peak [33].
Body mass index and visceral fat

Anthropomorphic measurements are made using standard laboratory equipment. Height and weight will be
used to determine body mass index (BMI, weight in kg/
height in meters2) as an index of total body fat. Waist
circumference (WC) is measured as an index of visceral
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fat. Waist circumference is only an indirect measure of
visceral fat, but budget constraints preclude more direct
measurement of visceral fat. Nevertheless, combined use
of BMI and waist circumference has been shown to be a
good predictor of mortality [34].
Laboratory assays from blood products
Blood sampling

Blood draws are performed following an 8 hour fast.
Participants will be asked to refrain from taking aspirin
and other anti-inflammatory medications for 48 hours
prior to the blood draw. Twenty milliliters of whole venous blood will be drawn into standard vacutainer tubes
by trained personnel. Standard separation procedures
will be used for collection of serum and plasma. Samples
will be stored at −80°C until future analysis.
Blood analysis

The blood components of interest will be measured in
duplicate by LabCorp® clinical trials division. All samples
are being analyzed by a LabCorp professional at a central
location that undergoes rigorous quality assurance testing
to deliver high accuracy and reliability in the results.
Self-report questionnaires
Drug abuse screening test (DAST)

The DAST is a 28-item self-report questionnaire that
provides quantitative index of problems related to drug
misuse [35]. The DAST has been validated with an internal consistency of .92 [35]. A score of 6 or greater is
suggestive of significant drug misuse which was used as
part of the exclusion criteria.
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Medication

Because medication use and change in medications
could be a confounding factor, all medications will be
recorded by self-report, including drug name and specific dosage, at the 0, 18, and 36 week time points. Medication changes that are determined to be significant will
be included as covariates during data analysis, however
changes in medications will not exclude or drop the participants from the study.
Perceived stress scale (PSS)

The 10-item PSS assesses the degree to which an individual finds life events unpredictable, uncontrollable, or
overwhelming [37]. Internal consistency has been demonstrated by a Cronbach’s alpha of 0.78 [37]. Validity of
the PSS is supported by significant correlations with
greater help-seeking, poorer health, more health service
utilization, and poorer life satisfaction [37].
MOS 36-item short-form health survey (SF-36)

The SF-36 is a widely-used and validated self-report
measure of health-related quality of life [38,39]. It consists of eight health concepts including physical function,
social function, pain, mental health, energy/fatigue, general health perceptions, role limitations due to physical
problems, and role limitations due to emotional problems. The SF-36 can be divided into the two parts: the
Mental Composite Score (MCS) and the Physical Composite Score (PCS). The internal consistency reliability
coefficients are high for its eight scales and ranges from
0.78 to 0.93 [40].
Centers for epidemiologic studies-depression (CES-D)

Michigan alcohol screening test (MAST)

The MAST is a 25-item self-report questionnaire that
provides rapid and effective screening for alcohol-related
problems and alcoholism. Test-retest reliability for the
MAST has been reported as .84 [36], however, Boyd
reported a reliability of .94 in rural women substance
abusers [36]. A score of 5 or greater is suggestive of significant alcohol dependency which was used as part of
the exclusion criteria.

The 20-item CES-D is a widely-used and validated selfreport measure of depressive symptoms [41,42]. Components of the CES-D include depressed mood, feelings of
guilt and worthlessness, feelings of hopelessness and
helplessness, psychomotor retardation, loss of appetite,
and sleep disturbance. The CES-D has a high internal
consistency in both the general population (.85) and in
patient populations (.90) [41].
Theory-based measures

Sociodemographic data

Sociodemographic characteristics was obtained to provide a description of the participants in the study and to
assess the generalizability of the results. Variables include age, gender, race, income, educational level, employment and marital status, as well as the number of
children living in the household and previous medical
conditions. Additionally, information was collected from
the participants to describe the usual care (pharmacological and psychological) they receive to control this as
a potential confounder.

Several self-report measures were chosen to measure the
theoretical constructs which form the basis of our intervention. These measures will allow us to examine whether
the intervention changed constructs that are proposed by
social cognitive theory and the transtheoretical model to
be mediators of change. While it would be ideal to collect
data on all of the constructs from these two theories, we
have selected to focus on those most widely used in intervention studies in order to reduce participant burden.
The Self-Efficacy for Exercise Questionnaire consists
of 14 items that ask participants to rate their confidence
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to be physically active (ranging from 0% to 100%) when
faced with commonly-cited barriers (e.g., when tired,
depressed, have a lot of work to do, etc.) [43]. This questionnaire has been shown to be valid and reliable across
race, education, gender, and weight categories [44]. Internal consistency was high for all subgroups (α = .90
to .94) and criterion-related validity was established
across subgroups.
Social support for PA will be assessed with a commonlyused 13-item scale developed by Sallis and colleagues
[45]. This scale has show acceptable test-retest reliability
(r = 0.55 to 0.86) and internal consistency (α = 0.61 to 0.91),
as well as concurrent criterion-related validity [45].
Self-regulatory behavior will be assessed with a 20item scale that assesses the degree to which participants
self-monitor, set goals, and problem solve [46]. The measure has been shown to have high internal consistency
(α = .89 for goals, .87 for plans) and strong associations
with PA [46].
Decisional balance will be assessed with a commonly
used 16-item (10 pros, 6 cons) scale developed by Marcus
and colleagues [47]. This scale has shown acceptable internal consistency (α = 0.79 for cons; 0.95 for cons) and
significant associations with stage of readiness for change.
Finally, the five cognitive and 5 behavioral processes of
change will be measured with a commonly-used 20-item
scale (2 items for each process) developed by Marcus
and colleagues [48]. Factor analysis has revealed two
higher order constructs (cognitive/experiential and behavioral processes), and those in early stages of change
report greater use of cognitive processes and less use of
behavioral processes, and vice versa for those in later
stages [48].
Statistical analysis

Descriptive baseline characteristics for group comparisons will be tabulated as means and standard deviations
(SD) or as percentages. Differences between the two
groups in the primary outcome will be tested according
to the intention-to-treat philosophy. All randomized participants will be analyzed according to their group assignment at randomization, regardless of adherence to
the intervention. The primary comparison is the difference in the amount of moderate-intensity physical activity between the intervention group and the standard
care group at 18 and 36 weeks of the intervention, respectively. Secondary, tertiary, and exploratory analyses
will focus on the other outcomes and subgroups, and
findings will be interpreted cautiously. All analyses will
take into account pre-specified covariates, including age,
gender, race, education, smoking status, response sets,
medication changes, and baseline values of outcome measures. Analyses of continuous outcome measures will be
based on analysis of covariance (ANCOVA) models of 18-
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and 36-month change scores since baseline and treatment
effects will be summarized as least-squares adjusted
means [49]. Analysis of binary outcomes will be based on
logistic regression, and analyses of ordered polytomous
outcomes will be based on ordered logit proportionalodds models [50]. The potential effects of missing data
will be explored under various models for nonignorable
missing data mechanisms, and through multiple imputation models under ignorable missing data assumptions
[51]. An α level of 0.05 will be used to indicate statistical
significance.
Power calculation

For a feasibility study, power is not a major consideration. However, being able to detect moderately large
differences between groups is reasonable. Assuming a
Type I error rate of α = 0.10 and 80% power, we can detect a difference between the intervention and control
groups in the change in PA of 0.55 standard deviation
units. That is, if the standard deviation of accelerometrybased PA is 120 min/week MPA and the pre-post correlation is 0.4, we can detect a difference of 80 minutes/
week. A major goal of this study is to generate data to
inform development of a larger randomized trial of this
community-based PA intervention. The data will therefore be used to generate descriptive statistics (means and
standard deviations) for the various physiological risk
factors for cardiovascular disease and their corresponding activity-induced changes across the intervention in
this unique population.
Baseline results
Participant recruitment

Figure 1 shows the flow of participants through the recruitment and randomization phase of the study. A total
of 95 phone screenings were conducted, of which 84
were considered eligible after preliminary screening and
invited to attend the orientation session. The most common reason for ineligibility following the phone screen
included not currently on ART. Of those invited to attend the orientation session, 8 were no shows and could
not be re-scheduled, 2 were found ineligible, and 74
were scheduled to return for the run-in visit for further
data collection. The total number of participants who
attended the run-in session was 72, with 2 no shows, in
which all who attended were invited to the final baseline
session. Prior to randomization, but after the baseline
measurement was conducted, 3 participants (4%) were
further excluded due to uncontrollable hypertension
which is a contraindication to exercise testing. Any participant unable to complete the graded exercise test was
not cleared for study participation by the medical supervisor. Thus, 94% of those consented and measured at
baseline were randomized to an intervention condition.
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Table 2 Baseline characteristics of participants
Characteristic

Intervention (n = 34)

Control (n = 34)

Total (n = 68)

Gender, % (n)
Male

47.1 (16)

44.1 (15)

45.6 (31)

Female

52.9 (18)

55.9 (19)

54.4 (37)

White

14.7 (5)

8.8 (3)

11.8 (8)

Black/African American

79.4 (27)

85.3 (29)

82.4 (56)

>1 category

2.9 (1)

2.9 (1)

2.9 (2)

Yes

2.9 (1)

5.9 (2)

4.4 (3)

No

97.1 (33)

94.1 (32)

95.6 (65)

Age in years, Mean ± SD

49 ± 11

48 ± 10

48 ± 10

0

0

0

Race, % (n)

Hispanic ethnicity, % (n)

Education, % (n)
Never attended school
Grades 1-8

0

0

0

Grade 9-11

14.7 (5)

14.7 (5)

14.7 (10)

Grade 12 or GED

23.5 (8)

26.5 (9)

25.0 (17)

Some college

38.2 (13)

44.1 (15)

41.2 (28)

College grad

23.5 (8)

14.7 (5)

19.1 (13)

Married

8.8 (3)

11.8 (4)

10.3 (7)

Divorced

23.5 (8)

11.8 (4)

17.6 (12)

Maritial status, % (n)

Widowed

5.9 (2)

8.8 (3)

7.4 (5)

Separated

11.8 (4)

11.8 (4)

11.8 (8)

Never married

47.1 (16)

32.4 (11)

39.7 (27)

Couple/Significant Other

2.9 (1)

23.5 (8)

13.2 (9)

Employed

29.4 (10)

44.1 (15)

36.7 (25)

Not employed

35.3 (12)

20.6 (7)

28.0 (19)

Student

2.9 (1)

5.9 (2)

4.4 (3)

Employment status, % (n)

Retired

2.9 (1)

2.9 (1)

2.9 (2)

Unable to work

29.4 (10)

20.6 (7)

25.0 (17)

$0-9,999

29.4 (10

35.3 (12)

32.4 (22)

$10,000- 19,999

26.5 (9)

20.6 (7)

23.5 (16)

$20,000- 29,999

14.7 (5)

11.8 (4)

13.2 (9)

$30,000- 39,999

5.9 (2)

17.6 (6)

11.8 (8)

$40,000- 49,999

2.9 (1)

2.9 (1)

2.9 (2)

$50,000- 59,999

0

2.9 (1)

1.5 (1)

Prefer not to say

20.6 (7)

8.8 (3)

14.7 (10)

0

85.3 (29)

76.5 (26)

80.9 (55)

1

2.9 (1)

11.8 (4)

7.4 (5)

2

5.9 (2)

5.9 (2)

5.9 (4)

Income, % (n)

Children in household, % (n)
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Table 2 Baseline characteristics of participants (Continued)
3

0

2.9 (1)

1.5 (1)

≥4

5.9 (2)

0

3 (2)

Weight in pounds, Mean ± SD

191.48 ± 58.59

192.14 ± 49.38

191.81 ± 53.76

BMI (kg/m2), Mean ± SD

30.04 ± 8.38

30.79 ± 7.90

30.42 ± 8.09

Waist circumference, Mean ± SD

98.74 ± 20.96

99.22 ± 18.54

98.98 ± 19.63

Systolic (mmHg)

127 ± 16

130 ± 14

128 ± 15

Diastolic (mmHg)

83 ± 10

83 ± 10

83 ± 10

Blood Pressure, Mean ± SD

Self-reported conditions %(n)
Heart condition
Yes

0

0

0

No

100 (34)

100 (34)

100 (68)

Yes

2.9 (1)

8.8 (3)

6 (4)

No

97.1 (33)

91.2 (31)

94 (64)

Cancer

Diabetes
Yes

5.8 (2)

20.6 (7)

13.2 (9)

No

94.2 (32)

79.4 (27)

86.8 (59)

Yes

36.4 (12)

33.3 (11)

34.8 (23)

No

63.6 (21)

66.7 (22)

65.2 (43)

High Cholesterol

Hypertension
Yes

45.5 (15)

48.5 (16)

47 (31)

No

54.5 (18)

51.5 (17)

53 (35)

Yes

17.6 (6)

6.1 (2)

11.9 (8)

No

82.4 (28)

93.9 (31)

88.1 (59)

Sleep apnea

Arthritis
Yes

20.6 (7)

12.1 (4)

16.4 (11)

No

79.4 (27)

87.9 (29)

83.6 (56)

Yes

17.6 (6)

15.6 (5)

16.7 (11)

No

82.4 (28)

84.4 (27)

83.3 (55)

Cholsterol (mg/dL)

188.89 ± 52.92

186.59 ± 38.55

187.76 ± 46.01

Triglycerides (mg/dL)

156.39 ± 146.87

130.59 ± 84.44

143.73 ± 119.95

LDL (mg/dL)

109.56 ± 35.98

107.41 ± 36.68

108.48 ± 36.00

HDL (mg/dL)

45.86 ± 20.58

52.96 ± 24.60

49.35 ± 22.71

Hepatitis C

Fasting blood analysis, Mean ± SD

VLDL (mg/dL)

26.19 ± 11.14

26.22 ± 16.90

26.20 ± 14.17

Glucose (mg/dL)

106.93 ± 48.22

111.33 ± 34.41

109.09 ± 41.69

C-Reactive Protein (mg/L)

4.76 ± 5.53

5.49 ± 5.96

5.12 ± 5.70

Interleukin-6 (pg/mL)

5.16 ± 7.11

4.07 ± 1.95

4.55 ± 4.88
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Participant characteristics

Demographic and health-related baseline characteristics
of the study sample are presented in Table 2. Intervention and Control participants did not differ significantly
(p > 0.05) on any characteristic at baseline. Most of the
participants self-identified as African-American (82.4%)
and female (54.4%). The average age was 40 years and
most participants were either singe/never married
(39.7%) or divorced (17.6%). Although majority have
some college education (41.2%), only 19% of the study
participants have a college degree and more than half
are out of work by self-identifying as either unemployed
(28%) or unable to work (25%).

Discussion
While combination antiretroviral therapy has dramatically extended the life expectancy of those infected with
human immunodeficiency virus (HIV), there is a high
prevalence of comorbidities that increase the risk of cardiovascular morbidity and mortality in the general population, and people living with HIV/AIDS (PLWHA)
[52,53]. The side effects associated with antiretroviral
therapy (ART) lead to multiple metabolic disorders,
making the management of these metabolic issues and
risk of cardiovascular disease (CVD) in those treated
with ART a critical issue. Studies indicate that even relatively modest increases in physical activity (PA) can increase cardiorespiratory fitness, reduce visceral fat and
increase muscle mass, reduce serum total and LDL/
VLDL cholesterol and triglycerides, and increase serum
HDL cholesterol within the general population [54-56],
and similar results have begun to emerge in regards to
PLWHA [57,58]. Due to the low socio-economic status
of this particular population it is extremely important
that a feasible and cost-effective program be implemented, such as routine physical activity, to help them
manage the metabolic complications associated with
ART. This study will evaluate a telephone delivered
home-based PA program designed to increase PA among
PLWHA. Further, it will evaluate the effectiveness of
such a program to decrease modifiable risk factors for
CVD as a secondary outcome. To our knowledge there
are no data available on the outcomes, in terms of either
program adherence or risk factor reduction, of a homebased PA/exercise training program when prescribed to
PLWHA. This gap in knowledge regarding home-based
training for community-dwelling patients is of special
concern considering the disproportionate prevalence of
HIV infection in poor, rural, and minority populations
who have limited access to exercise training facilities
and professional support.
PA has been shown in center-based clinical trials to reduce CVD risk factors in PLWHA and home-based PA
programs have produced benefits in numerous clinical
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and healthy populations. This study will allow us to test
methods and collect process evaluation data with the
goal of disseminating an effective approach to increasing
PA levels to reduce CVD risk in PLWHA. A secondary
goal of this study is to provide a preliminary assessment
of activity-induced changes to CVD risk factors including cardiorespiratory fitness, blood lipids and markers of
systemic inflammation. Currently this study is in the
final stages of data collection. All participants have been
recruited and randomized.
Abbreviations
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